Company news

Alcon AG news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief

September 28, 2026

Clareon PanOptix Pro and the UNITY Platform Lead Alcon's Surgical Innovations at ESCRS 2026

September 8, 2026

Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control

September 3, 2026

Alcon Prices EUR 500 Million Senior Notes Offering

August 26, 2026

Second-Quarter 2026 Earnings Call Regulatory Filing

August 11, 2026

Earnings Document (Q2 2026 Press Release)

August 10, 2026

Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India

July 24, 2026

Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada

June 15, 2026

2026 Annual General Meeting Minutes from Meeting

May 16, 2026

New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds

May 5, 2026

US Startup PerZeption Inc. Announces Collaboration with Alcon Research

May 1, 2026

Alcon Announces Results of 2026 Annual General Meeting

April 30, 2026

Centurion Service Group and Auction Advisors announce major auction of assets from Fromer Eye Centers

April 29, 2026

Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform

April 23, 2026

National Advertising Division Finds Certain ACUVUE® Oasys Max Claim Supported; Recommends Modification or Discontinuation of Others

April 20, 2026

Mexican Gold Mining Corp. and Alcon Silver Corp. Announce Arrangement Agreement to Create a Diversified Precious Metals Exploration Company

April 9, 2026

Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada

April 7, 2026

Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026

April 6, 2026

Alcon Publishes Agenda for 2026 Annual General Meeting

April 2, 2026

Nanoscope Therapeutics Appoints Ophthalmology Industry Veteran Paul Hallen as Chief Operating Officer to Advance Global Commercial Readiness

April 1, 2026

Algoma Central Corporation Announces Renewal of Normal Course Issuer Bid

March 19, 2026

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

March 16, 2026

Alcon Surpasses 175 Million IOLs Implanted Globally

March 2, 2026

Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

February 24, 2026

Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology

February 17, 2026

Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

February 2, 2026

Alcon Completes $750 Million Share Repurchase Program

January 20, 2026

J.P. Morgan Healthcare Conference Presentation

January 13, 2026

Alcon Terminates Agreement to Acquire STAAR Surgical

January 6, 2026

Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference

December 30, 2025

Alcon Announces Amended Merger Agreement with STAAR Surgical

December 9, 2025

Opterion Health AG Announces Appointment of Andreas Schuh as Chief Financial Officer

December 1, 2025

Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds

November 11, 2025

Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders

November 4, 2025

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon

October 27, 2025

Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

October 23, 2025

STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote "FOR" the Alcon Merger Agreement on WHITE Proxy Card

October 8, 2025

Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon

October 7, 2025

STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis

October 6, 2025

Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR

September 30, 2025

Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS

September 16, 2025

Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025

September 8, 2025

OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio

September 3, 2025

Alcon to Present at 2025 Baird Global Healthcare Conference

August 26, 2025

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical

August 19, 2025

Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS

August 18, 2025

Alcon Agrees to Acquire STAAR Surgical

August 5, 2025

Alcon’s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval

July 8, 2025

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

July 7, 2025

Alcon Canada Earns Global Recognition as a Top Employer

June 26, 2025

Older news releases →

Calls

The 5 newest of 29 calls. Every call is listed under its year.

Decks

The 5 newest of 89 decks. Every deck is listed under its year.